Skip to content

Medical-device intelligence

ONX: Ovarian Adnexal Mass Assessment Score Test System

FDA product code ONX: Ovarian Adnexal Mass Assessment Score Test System. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
ONX
FDA device name
Ovarian Adnexal Mass Assessment Score Test System
Device class
2
Regulation number
866.6050
Medical specialty
Obstetrics/Gynecology
Review panel
IM

FDA definition

An ovarian/adnexal mass assessment test is a devicem that measures one or more proteins in serum. It yields a single result for the likelihood that an adnexal pelvic mass in a woman, for whom surgery is planned, is malignant. The test isn for adjunctive use, in teh context of a negative primary clinical and radiological evaluation, to augmrent the identification of patienets whose gynecologic surgery requires oncology expertise and resources.
Explore obstetrics/gynecology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

5 clearance records and 0 recall records in the covered releases, across 3 source company names and 1 product codes. Dated history runs from Sep 1, 2011 to Jun 15, 2016.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
ONX · Ovarian Adnexal Mass Assessment Score Test System50

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

5 matching records
Device / recordCompany in FDA recordSourceSource date
ROMA Calculation Tool Using Elecsys AssaysK153607 · ONXRoche Diagnostics510(k)Jun 15, 2016FDA decision date
Lumipulse G ROMAK160090 · ONXFujirebio Diagnostics,Inc.510(k)May 16, 2016FDA decision date
ARCHITECT ROMAK151502 · ONXFujirebio Diagnostics,Inc.510(k)Apr 28, 2016FDA decision date
OVA1 Next GenerationK150588 · ONXVermillion, Inc.510(k)Mar 18, 2016FDA decision date
ROMA (HE4 EIA + ARCHITECT CA 125 II)K103358 · ONXFujirebio Diagnostics,Inc.510(k)Sep 1, 2011FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗